Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 829-832

  Dahlgren, Liselotte ^a   Erlandsson, Fredrik ^a   Lindquist, David ^a   Silfverswärd, Claes ^a   Hellström, Ann Cathrin ^a   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical neoplasia; Cervical squamous cell carcinoma; Papillomavirus

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

ADULT; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 33645803857     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6): 518-527, 2003.
2. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C and Wilander E: The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 37(2): 246-250, 2001.
3. Ho GY, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7): 423-428, 1998.
4. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL et al: Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103(4): 519-524, 2003.
5. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK et al: Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355(9222): 2189-2193, 2000.
6. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA et al: Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 98(4): 590-595, 2002.
7. Moberg M, Gustavsson I and Gyllensten U: Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 112(5): 854-859, 2004.
8. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M et al: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102(2): 152-158, 2002.
9. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 83 Suppl 1: ix-xxii, 1-229, 2003.
10. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B and Walaas L: The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 9(3): 113-117, 1992.
11. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4): 1057-1062, 1995.
12. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ et al: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42(2-3): 265-279, 1993.
13. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J et al: Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus- positive and -negative tumors. Int J Cancer 107(2): 244-249, 2003.
14. Moberg M, Gustavsson I, Wilander E and Gyllensten U: High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92(5): 891-894, 2005.
15. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U and Johansson B: Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92(12): 2195-2200, 2005.